The Research Society for the Study of Diabetes in India (RSSDI) has decided to distribute free insulin among children below the age of 15 years across the country.
Type 1 diabetes among children and adolescents are on rise. It is reported that 10 to 15 children per 1,00,000 under the age of 15 years develop Type 1 diabetes every year.
Advertisement
Most of these children depend on insulin for survival and require insulin injections to keep their blood sugar level under control. RSSDI aims to control the fluctuating blood sugar levels by distributing free insulin.
India is among one of the top countries in the world where the severity of diabetes is so high. Children as young as 3 to 4 years are being diagnosed with type 1 diabetes in India.
![Subset of Patients With Strong Response to Therapy Identified By ITN Type 1 Diabetes Study]( "Subset of Patients With Strong Response to Therapy Identified By ITN Type 1 Diabetes Study")
Patients with type 1 diabetes treated with the monoclonal antibody teplizumab exhibit greater preservation of C-peptide, compared to controls, according to a new clinical trial.
Dr S.V. Madhu, President of RSSDI, said, "We recognized that the number of children who depended on insulin for diabetes management is also vast. But the bigger problem that we noticed was that insulin was inaccessible to many children particularly due to its cost, which makes it unaffordable. Also, many states in the country do not provide free insulin putting children at more risks."
Children of states where government agencies are not able to provide free insulin will be benefited with this initiative. The decision was taken in a two-day national executive meet recently.
RSSDI will set up a national registry for identification of diabetic children who are deprived of insulin so that all those who are in need could benefit from its initiative.
Source: Medindia
Subset of Patients With Strong Response to Therapy Identified By ITN Type 1 Diabetes Study
Patients with type 1 diabetes treated with the monoclonal antibody teplizumab exhibit greater preservation of C-peptide, compared to controls, according to a new clinical trial.
Advertisement
Dr S.V. Madhu, President of RSSDI, said, "We recognized that the number of children who depended on insulin for diabetes management is also vast. But the bigger problem that we noticed was that insulin was inaccessible to many children particularly due to its cost, which makes it unaffordable. Also, many states in the country do not provide free insulin putting children at more risks."
Children of states where government agencies are not able to provide free insulin will be benefited with this initiative. The decision was taken in a two-day national executive meet recently.
RSSDI will set up a national registry for identification of diabetic children who are deprived of insulin so that all those who are in need could benefit from its initiative.
Source: Medindia
A Key Factor in Mortality in Type 1 Diabetes Is Social Deprivation: Study
An independent risk factor for mortality in people with type 1 diabetes are the levels of social deprivation, as well as how well a patient controls their blood sugar.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Child Health News
Playing in early childhood is key to shaping a healthier brain, as emphasized by a top expert.
Side-effects of valproate drug taken during pregnancy, enhance the expression of Rnf146 gene, causing autism spectrum disorder in fetus.
Children with amblyopia or lazy eye who underwent digital vision training, showed no appreciable improvement in their eyesight.
In 2022, over 20% of children worldwide lacked adequate calories for growth, with 45+ million showing wasting (underweight for height).
After PCV7 licensure, pneumococcal infection rates in children aged 5+ with sickle cell disease significantly decreased.
